Next-Generation In Silico Cardiac Safety & Arrhythmia Risk Profiling
Proprietary biophysical and computational framework compliant with FDA CiPA and OECD guidelines. Operating in stealth mode pending patent finalization and strategic licensing partnerships.
Confidential De-risking Architecture for Life Sciences
HeartSim AI® addresses the multi-billion-dollar false-positive attrition trap in safety pharmacology without disclosing internal proprietary computational mechanics prior to patent closure.
Zero False-Positive Elimination
Overcomes the legacy hERG single-channel bottleneck by modeling multi-channel electrophysiological balance, eliminating false candidate attrition.
Regulatory Alignment (CiPA & OECD)
Directly mapped to FDA Comprehensive In Vitro Proarrhythmia Assay (CiPA) endpoints (qNet in µC/µF) and OECD Principles 1-5 for model validation.
100% Air-Gapped Confidentiality
Shipped as an isolated on-premises runtime. Zero telemetry, zero cloud egress. Proprietary compounds and chemical structures never leave client perimeter.
Strategic IP Acquisition & Licensing
Engineered as an institutional IP asset available for exclusive enterprise licensing, full patent transfer, or co-development with pharmaceutical leaders.
100% Blind Concordance on FDA CiPA Reference Drugs
Validated across the complete FDA CiPA 12-drug panel (Dofetilide, Quinidine, Bepridil, Sotalol, Cisapride, Terfenadine, Ondansetron, Astemizole, Verapamil, Ranolazine, Mexiletine, Diltiazem) with zero clinical false positives.
Licensing Models & IP Acquisition
Structured for flexible engagement with global pharmaceutical sponsors, emerging biotech ventures, and strategic acquirers.
Enterprise On-Premises License
Air-gapped deployment across corporate discovery pipelines for pre-synthesis high-throughput library triage.
Inquire Under NDAFull Intellectual Property Acquisition
Complete transfer of proprietary source architecture, mathematical frameworks, and pre-trained models for in-house monopoly.
Inquire Under NDACommercial Service Integration
White-label in silico cardiosafety reporting package to augment high-throughput patch-clamp and telemetry services.
Inquire Under NDARequest Executive Dossier & Bilateral NDA
Due to ongoing patent filings and trade secret protection, full technical documentation and benchmark logs are shared strictly under bilateral Swiss Non-Disclosure Agreements.
Request Executive Dossier & Bilateral NDA
Due to ongoing patent filings and trade secret protection, full technical documentation and benchmark logs are shared strictly under bilateral Swiss Non-Disclosure Agreements.